The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

Whether it is talking about life, tattoos or dogs ruining the carpet, Ozzy always had the best thing to say every time.

GSK Starts Shipping Trivalent Flu Vaccines To U.S. Healthcare Providers For 2025-26 Season July 10, 2025 — 09:24 am EDT Written by RTTNews.com for RTTNews -> ...

Moderna says mRNA flu vaccine sailed through trial, beating standard shot Moderna hailed the results, but the shot's future under RFK Jr. is murky.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...

Studies suggest that people who had seasonal flus or vaccinations have low antibody levels against H5N1 bird flu.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced Monday.

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines. The shot’s efficacy was 27 percent ...

As the respiratory virus season approaches, the director of immunization for a national pharmacy chain said that it is important to plan vaccinations ahead of time.

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial.

The current seven-member panel also recommended routine annual flu vaccination during the upcoming 2025-2026 flu season for everyone 6 months of age and older who do not have contraindications.